2026 NPPES data Ph.D. Medical Genetics NPI 1356568752 M.D.
Verify on CMS →

ERLINDA GREY, M.D.

Ph.D. Medical Genetics in PANORAMA CITY, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
12K
Medicare Part D claims · 543 beneficiaries · Ph.D. Medical Genetics avg: 984
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$542.35
29 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ERLINDA GREY, M.D. is a Ph.D. Medical Genetics ([object Object]) practicing in PANORAMA CITY, California with a Medicare Part D prescribing footprint of 12K claims across 543 beneficiaries — 15% brand-name prescribing . Industry payments of $542.35 across 29 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ERLINDA GREY, M.D. filed 12,307 Medicare Part D claims in 2023 across PANORAMA CITY, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ERLINDA GREY, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 04/19/2007

NPI 1356568752

Primary specialty

Ph.D. Medical Genetics

Rare

357 US NPIs in this specialty

Medicare Part D claims

12,307 1151% vs specialty avg

2023 prescription claims

Specialty avg: 984

Specialty distribution in California

How Ph.D. Medical Genetics compares to other specialties among California providers

California providers

Ph.D. Medical Genetics share within California

1. Ph.D. Medical Genetics42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ph.D. Medical Genetics share within California

Specialty board-certification context

Estimated specialty board-certified rate — Ph.D. Medical Genetics (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ph.D. Medical Genetics ABMS/AOA estimate

Est. board-certified rate (Ph.D. Medical Genetics) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ph.D. Medical Genetics) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ERLINDA GREY, M.D. is a Ph.D. Medical Genetics provider practicing in PANORAMA CITY, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1356568752. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ERLINDA GREY, M.D. appears in the CMS NPPES registry as a Ph.D. Medical Genetics provider holding M.D. credentials at 8215 VAN NUYS BLVD, PANORAMA CITY, CA, 91402, with a listed phone of (818) 901-0373. NPI 1356568752 was issued on 04/19/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GREY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 12,307 prescription claims written by this provider, covering 543 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ph.D. Medical Genetics is a narrow specialty nationwide, with 357 enrolled providers across 46 states and an average of 984 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8215 VAN NUYS BLVD
PANORAMA CITY, CA 91402

Provider Details

NPI 1356568752
Specialty Ph.D. Medical Genetics
Credentials M.D.
Gender Female
NPI Issued 04/19/2007

Hospital and facility affiliations

Facilities where ERLINDA GREY, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CARE COMMUNITY HEALTH CENTERS
PANORAMA CITY, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ERLINDA GREY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$542

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ERLINDA GREY, M.D.. To verify ERLINDA GREY, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ERLINDA GREY, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 12,307 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

12,307
Total Claims
$1.4M
Total Drug Cost
543
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
23,534
Total Day Supply
681,816
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$1.1M
Generic Drug Cost
$289K
Opioid Claims
105 (0.9% rate)
Antibiotic Claims
328

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.20
Gender Split
65% female / 35% male
Age Distribution
<65: 30, 65-74: 301, 75-84: 166, 85+: 46

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Diclofenac Sodium
549
Metformin Hcl
523
Atorvastatin Calcium
484
Losartan Potassium
475
Amlodipine Besylate
416
Simvastatin
399
Gabapentin
301
Montelukast Sodium
284
Omeprazole
264
Levothyroxine Sodium
249

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ph.D. Medical Genetics Overview

How ERLINDA GREY, M.D. fits within the Ph.D. Medical Genetics landscape nationally.

357
Ph.D. Medical Genetics Providers in US
46
States with Ph.D. Medical Genetics
984
Avg Claims per Provider

ERLINDA GREY, M.D.'s 12,307 claims are above the specialty average of 984.

Nearby Ph.D. Medical Genetics Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GREY.

Compare Ph.D. Medical Genetics nationally: see state-by-state distribution →

Frequently Asked Questions

What is ERLINDA GREY, M.D.'s specialty?
ERLINDA GREY, M.D. specializes in Ph.D. Medical Genetics and practices in PANORAMA CITY, California. Credentials: M.D..
How much does ERLINDA GREY, M.D. prescribe under Medicare Part D?
In 2023, ERLINDA GREY, M.D. wrote 12,307 Medicare Part D claims totaling $1.4M in drug costs for 543 beneficiaries.
Where is ERLINDA GREY, M.D. located?
ERLINDA GREY, M.D. is located at 8215 VAN NUYS BLVD, PANORAMA CITY, CA, 91402. Phone: (818) 901-0373.
What is ERLINDA GREY, M.D.'s NPI number?
ERLINDA GREY, M.D.'s National Provider Identifier (NPI) is 1356568752, issued on 04/19/2007.
Does ERLINDA GREY, M.D. prescribe more brand-name or generic drugs?
ERLINDA GREY, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $1.1M in brand drug costs.
Does ERLINDA GREY, M.D. prescribe opioids?
Yes, ERLINDA GREY, M.D. had 105 opioid claims in 2023 with an opioid prescribing rate of 0.9%.
How many Ph.D. Medical Genetics providers are there in the US?
There are 357 Ph.D. Medical Genetics providers across 46 states in the US. The average Ph.D. Medical Genetics provider writes 984 Medicare Part D claims per year.
What drugs does ERLINDA GREY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ERLINDA GREY, M.D.'s most frequently prescribed drugs include Diclofenac Sodium, Metformin Hcl, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ERLINDA GREY, M.D. accept Medicare?
ERLINDA GREY, M.D. appears in CMS Medicare data with 12,307 Part D claims and 543 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ERLINDA GREY, M.D.'s credentials?
ERLINDA GREY, M.D.'s NPI is 1356568752 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology